KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Account Payables (2016 - 2026)

Bristol Myers Squibb has reported Change in Account Payables over the past 18 years, most recently at $409.0 million for Q1 2026.

  • Quarterly Change in Account Payables rose 581.18% to $409.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $492.0 million through Mar 2026, up 344.78% year-over-year, with the annual reading at -$2.0 million for FY2025, 101.09% down from the prior year.
  • Change in Account Payables was $409.0 million for Q1 2026 at Bristol Myers Squibb, up from -$90.0 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $517.0 million in Q4 2024 and troughed at -$374.0 million in Q3 2024.
  • The 5-year median for Change in Account Payables is $13.0 million (2025), against an average of $52.8 million.
  • The largest YoY upside for Change in Account Payables was 713.04% in 2023 against a maximum downside of 768.42% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at $405.0 million in 2022, then increased by 9.63% to $444.0 million in 2023, then rose by 16.44% to $517.0 million in 2024, then crashed by 117.41% to -$90.0 million in 2025, then soared by 554.44% to $409.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Change in Account Payables are $409.0 million (Q1 2026), -$90.0 million (Q4 2025), and $160.0 million (Q3 2025).